Our results presented above suggest that the aberrant activation of DNMT3B in breast cancer induces a hypermethylation of CpG rich DNA regions in the promoters of several onco-suppressor genes, responsible for the more aggressive profiles of tumour cells. The gene discussed is DNMT3B; the disease is breast cancer.